Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team
Essential Pharma, a global pharmaceutical company developing and delivering medicines for patients in niche populations, announces the appointment of Simon Ramsden as Chief Financial Officer and Rob Smith as Chief Technology Officer, both with immediate effect.
Simon brings over 20 years of pharmaceutical and healthcare industry experience in finance, business development, and M&A transactions. He was most recently CFO at Resolution Therapeutics for two years, before which he served as VP, Head of Global Finance at EUSA Pharma, overseeing all financial operations across nine international locations.
Health Technology Insights: OneOncology, HOATC Partner to Advance Cancer Care in Florida
Prior to this, he spent nine years in senior finance roles at GSK, latterly managing a global budget in the Consumer Health R&D team. Simon is a member of the Institute of Chartered Accountants of Scotland with expertise spanning commercial finance partnering, business development, and leading cross-functional teams across organizations ranging from startups to multinationals.
Rob brings over 30 years of pharmaceutical industry experience across operations, product development, and manufacturing strategy. He was most recently CEO at Surepharm Services Ltd, before which he spent 11 years at Catalent Pharma Solutions across multiple senior roles.
Health Technology Insights: JLL Partners Announces Investment in Vascular Technology, Incorporated
Prior to this, Rob held several senior operational and development roles at Patheon Inc. and Sanofi-Aventis, where he spent over 12 years leading site development projects. Rob has a strong quality background and product development knowledge, with expertise in introducing new technology and innovation linked with continuous improvement to support business development and commercial strategy across the pharmaceutical sector.
Emma Johnson, CEO of Essential Pharma, commented: “We are thrilled to welcome Simon and Rob to our leadership team at this pivotal time for Essential Pharma. Simon’s financial leadership and deep understanding of the pharmaceutical industry will be crucial as we advance our development pipeline and pursue strategic opportunities for our growing portfolio. Rob’s broad experience in pharmaceutical operations and technology, combined with his track record of building successful teams, will help us accelerate our growth and enhance our operational excellence as we work to make a difference for patients in niche populations worldwide.”
Health Technology Insights: TRC Healthcare Launches Upgraded NatMed Pro Tools
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – GlobeNewswire
